JournalArta
Thursday, November 19, 2026 · JakartaS&P 7,323.63 ▼0.23%USD/IDR 18,257 ▲0.16%
JournalArta
Global Edition
beyond headlines
Advertisement

Regeneron Pharmaceuticals (REGN) Stock Falls 1.28% (November 18, 2026): Up 17.4% in a Month

Technical analysis of REGN stock on November 18, 2026: price 945.53 USD, trend uptrend, RSI 64.1, support 805.02, resistance 973.36.

By matthew jonathan
November 19, 20265 min read
Regeneron Pharmaceuticals (REGN) Stock Falls 1.28% (November 18, 2026): Up 17.4% in a Month
Logo Regeneron Pharmaceuticals — JournalArta illustration

Why REGN is in focus today

    Selected automatically from 11 NASDAQ (US) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

    Regeneron Pharmaceuticals closed at 945.53 USD on Wednesday, November 18, 2026, down 1.28% from the prior close of 957.76 — a modest pullback that nonetheless leaves the shares 17.36% higher over the past month and sitting 83% of the way up their 20-day trading range. That combination is the story: a stock in a confirmed uptrend taking a breather, not a stock breaking down. The question for readers is whether the pullback is a pause or the start of something deeper, and the indicators offer an unusually clear answer.
    Advertisement

    Trend & Price Action

    The structural picture remains firmly bullish. The last price sits above both the 20-day average at 901.91 and the 50-day average at 824.37, and the 20-day average itself rose 4.52% over the past five days — a slope that confirms the uptrend rather than merely reflecting an old rally. No new moving-average cross has formed, which matters: the stock is riding an established trend, not a fresh signal that needs re-validation. What gives the session its texture is the location within the range. With 20-day support at 805.02 and resistance at 973.36, the close at 945.53 leaves roughly 28 points to the resistance ceiling and the three-month high of 991.73 just beyond it. The three-month low of 722.02 is now far below — a reminder of how much ground has been recovered. The mild five-day decline of 1.45% against the one-month gain of 17.36% tells you the selling has been shallow and contained.
    Price action chart of REGN
    3-month price action chart of REGN: price, SMA20/50, Bollinger, support & resistance.
    Advertisement

    Oscillators & Momentum

    Momentum is where the caution enters. RSI(14) at 64.1 sits in neutral territory but, crucially, is rolling over from above 65 — a classic early sign that buying pressure is easing even as price holds near highs. The stochastic readings reinforce the message: %K at 69.7 has slipped below %D at 76.7, a bearish crossover in the making that often precedes short-term consolidation. The longer-horizon momentum measure disagrees, and that disagreement is informative. MACD at 39.911 remains above its signal line at 38.648, with a positive histogram of 1.262 — momentum is still on the bulls' side, just with a thinner cushion than a month ago. In practice, this setup describes a stock digesting a strong advance: the fast oscillators cool while the trend gauge holds. That is a pullback profile, not a reversal profile, and it lines up with the price action.
    Momentum chart of REGN
    Momentum chart of REGN: RSI(14), MACD, Stochastic.
    Advertisement

    Volatility & Volume

    Volatility is running hot. The Bollinger band width has expanded to 27.0%, with the upper band at 1,023.64 and the lower at 780.17, and %B at 68% places the close in the upper-middle of that envelope — room to run, but also room to swing. ATR(14) of 40.04 USD, or 4.2% of the price, quantifies the daily risk: readers should expect moves of that size to be routine rather than alarming. Volume is the one genuinely soft spot. The latest session's 705,100 shares came in at just 0.7× the 20-day average of 1,041,495 — thin participation behind the decline. Yet On-Balance Volume is rising, meaning the cumulative volume flow still favors accumulation. Thin selling into a rising OBV is a far more benign combination than heavy selling into a falling OBV; the pullback lacks conviction from the bear side.
    Advertisement

    Fundamental Context

    The technical resilience has a fundamental backdrop. According to its SEC filing, Regeneron reported quarterly revenue of $5.12 billion for the quarter ended September 30, 2026, up 36.3% from $3.75 billion a year earlier, with net income of $1.95 billion versus $1.46 billion and diluted earnings per share of $18.45. That is the kind of growth profile that gives a chart like this one its staying power — and it explains why dips toward the 20-day average have been absorbed rather than extended.

    Key Levels & Scenarios

    The levels to watch are unambiguous. On the upside, a close above 973.36 would clear 20-day resistance and open the path toward the three-month high at 991.73; the Bollinger upper band at 1,023.64 marks the next stretch target if that breakout holds. On the downside, the first real test is the 20-day average at 901.91, which coincides with the lower edge of the current entry zone. A failure to hold that area would shift attention to the 805.02 support — a level roughly 15% below the last close. The volume question cuts both ways. If the next session brings a bounce on volume above the 1.04 million 20-day average, the pullback is confirmed as a pause. If instead the stock loses 901.91 on heavy volume, the bearish RSI rollover would graduate from warning to signal.
    Advertisement

    Technical Verdict: BUY

    The verdict is BUY, supported by three factors. First, price sits above the 50-day average at 824.37 and the 20-day average is above the 50-day, an intact uptrend structure. Second, the recent dip represents a pullback to the SMA20 within that uptrend, the highest-quality entry pattern the trend offers. Third, OBV is rising, confirming that participation still leans to the accumulation side despite the soft session. The invalidation condition is explicit: the verdict fails if price breaks below the stop loss at 877.37. - Entry Range: 915.47 – 945.53 - Exit Target 1: 1,047.77 - Exit Target 2: 1,150.01 - Stop Loss: 877.37 - Reward/Risk: 1.5 to 3.0 | Setup valid until December 17, 2026 In plain terms: the trend and the momentum engine both still point higher, so the current dip reads as an opportunity within an advance rather than the start of a decline — though the RSI rollover and thin volume mean the next session's participation will decide how quickly that plays out. *This is technical analysis for educational purposes, not an investment recommendation. Prices are in USD as of the November 18, 2026 session.*
    Advertisement

    Summary Data REGN

    Last price945.53 USD
    Change 1 day / 5 days / 1 month-1.28% / -1.45% / 17.36%
    Trend / MA-crossuptrend / none
    SMA20 / SMA50901.91 / 824.37
    RSI (14) / Stochastic %K64.1 / 69.7
    Bollinger %B / ATR68% / 40.04
    Support / Resistance 20 days805.02 / 973.36
    Data as of19 November 2026 04:00 WIB
    JournalArta research verdict (score)Buy (+66)
    Entry zone915.47 – 945.53
    Target 1 / 21,047.77 / 1,150.01
    Stop loss877.37
    Reward/risk1.5 / 3.0

    Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

    Advertisement
    Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
    Advertisement
    Most Read
    1. 1Gold Silver Price November: Futures Rise Near Yearly Lows
    2. 2Michael Clarke Says Sandpapergate Scars Drew Steve Smith to New York
    3. 3U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
    4. 42027 NFL Mock Draft Puts Ohio State’s Jeremiah Smith at No. 1
    5. 5Brent Crude Slides 4.05% as Rising US Stockpiles Weigh on Oil
    Advertisement
    Don't Miss

    Latest News

    All stories →
    1. Technology · Apps & SoftwareUK NCSC Cyber Assessment Framework Playbook for IT and MSPsNov 19
    2. Technology · Apps & SoftwareAWS London vs Azure UK South vs Google Cloud Costs and ResidencyNov 19
    3. Markets · StocksBerkshire’s Kraft Heinz Stake Falls From $30 Billion to $8 BillionNov 19
    4. World · United StatesUS Army Plans Iowa Blast as Lead Dust Could Travel 100 MilesNov 19
    5. Advertisement
    6. Markets · StocksExelon (EXC) Stock Update: Rises 0.35%, Up 6.9% in a MonthNov 19
    7. World · AustraliaVictoria Labor Scraps Andrews-Era Glass Bin MandateNov 19
    8. Sport · More SportsCameron Bancroft Says Whole Australia Team Knew of Ball TamperingNov 19
    9. Lifestyle · Food & HealthTelehealth Consultations: How Doctors Can Improve CareNov 19